Long-term outcome of lung transplantation in a patient with the anti-synthetase syndrome

Sem, Marthe; Lund, MB; Molberg, Øyvind

doi:10.3109/03009742.2011.566280

Cited by 3 publications

(3 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Lung transplantation is the last treatment option in end-stage IIM-ILD, as reported in some anecdotal cases [131][132][133][134]. Courtwright et al reported that adjusted survival was not significantly different among subgroups of IIM-ILD patients compared with IPF patients after lung transplantation [135].…”

Section: Others (Intravenous Immunoglobulins Plasmapheresis Lung Trmentioning

confidence: 99%

See 1 more Smart Citation

Therapeutic Options for the Treatment of Interstitial Lung Disease Related to Connective Tissue Diseases. A Narrative Review

Vacchi

Sebastiani

Cassone

et al. 2020

JCM

View full text Add to dashboard Cite

Interstitial lung disease (ILD) is one of the most serious pulmonary complications of connective tissue diseases (CTDs) and it is characterized by a deep impact on morbidity and mortality. Due to the poor knowledge of CTD-ILD’s natural history and due to the difficulties related to design of randomized control trials, there is a lack of prospective data about the prevalence, follow-up, and therapeutic efficacy. For these reasons, the choice of therapy for CTD-ILD is currently very challenging and still largely based on experts’ opinion. Treatment is often based on steroids and conventional immunosuppressive drugs, but the recent publication of the encouraging results of the INBUILD trial has highlighted a possible effective and safe use of antifibrotic drugs as a new therapeutic option for these subjects. Aim of this review is to summarize the available data and recent advances about therapeutic strategies for ILD in the context of various CTD, such as systemic sclerosis, idiopathic inflammatory myopathy and Sjogren syndrome, systemic lupus erythematosus, mixed connective tissue disease and undifferentiated connective tissue disease, and interstitial pneumonia with autoimmune features, focusing also on ongoing clinical trials.

show abstract

Section: Others (Intravenous Immunoglobulins Plasmapheresis Lung Trmentioning

confidence: 99%

“…Prospective [106] Retrospective [81,[97][98][99][100]102,[107][108][109][110]112,114,115,117] Lung transplantation Retrospective [61,[63][64][65][66][67][68][69][70] Retrospective [133][134][135] Case report [131,132]…”

Section: Glucocorticoidsmentioning

confidence: 99%

Therapeutic Options for the Treatment of Interstitial Lung Disease Related to Connective Tissue Diseases. A Narrative Review

Vacchi

Sebastiani

Cassone

et al. 2020

JCM

View full text Add to dashboard Cite

show abstract

“…There are sparse reports of LTx in ASS and this may be an underutilised treatment modality for patients with ILD‐dominant ASS . Our case highlights the potential success of LTx in such patients.…”

mentioning

confidence: 99%

Bilateral lung transplantation in antisynthetase syndrome

Brown

Holmes‐Liew

Chapman

et al. 2019

Internal Medicine Journal

View full text Add to dashboard Cite

Pulmonary histopathology of interstitial lung disease associated with antisynthetase antibodies

Flashner

VanderLaan

Nurhussien

et al. 2022

Respiratory Medicine

View full text Add to dashboard Cite

Long-term outcome of lung transplantation in a patient with the anti-synthetase syndrome

Abstract: Scand J Rheumatol Downloaded from informahealthcare.com by University of Toronto on 12/07/14For personal use only.

Cited by 3 publications

References 9 publications

Therapeutic Options for the Treatment of Interstitial Lung Disease Related to Connective Tissue Diseases. A Narrative Review

Therapeutic Options for the Treatment of Interstitial Lung Disease Related to Connective Tissue Diseases. A Narrative Review

Bilateral lung transplantation in antisynthetase syndrome

Pulmonary histopathology of interstitial lung disease associated with antisynthetase antibodies

Contact Info

Product

Resources

About